Presentation TCT 2022 TARGET All Comers Trial 5-year Outcomes and Substudy Analysis Presenter: Alexandra Lansky September 18, 2022 REGISTER for free or LOG IN to view this content Coronary TCT 2022 Up Next Presentation TCT 2022 TARGET First: Short DAPT with Complete Revascularization Strategy Presenter: Giuseppe Tarantini September 18, 2022 More slides + Presentation TCT 2022 Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study Presenter: ShaoLiang Chen September 18, 2022 Presentation TCT 2022 Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study Presenter: Firas Zahr September 18, 2022 We Recommend Disclosures Nothing to disclose
Presentation TCT 2022 TARGET First: Short DAPT with Complete Revascularization Strategy Presenter: Giuseppe Tarantini September 18, 2022
Presentation TCT 2022 Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study Presenter: ShaoLiang Chen September 18, 2022
Presentation TCT 2022 Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study Presenter: Firas Zahr September 18, 2022